| RS1700091023 |
SCN2A
|
Health Risk |
Likely pathogenic |
Complex neurodevelopmental disorder, SCN2A-related disorder |
| RS1700091133 |
SCN2A
|
Health Risk |
Likely pathogenic |
— |
| RS1700129673 |
CPS1
|
Health Risk |
Likely pathogenic |
Pulmonary hypertension, neonatal |
| RS1700129715 |
CPS1
|
Health Risk |
Likely pathogenic |
Congenital hyperammonemia, type I |
| RS1700132195 |
CPS1
|
Health Risk |
Likely pathogenic |
Congenital hyperammonemia, type I |
| RS1700146530 |
ABCA12
|
Health Risk |
Pathogenic |
— |
| RS1700257346 |
CPS1
|
Health Risk |
Likely pathogenic |
Congenital hyperammonemia, type I |
| RS1700264768 |
CPS1
|
Health Risk |
Pathogenic |
Congenital hyperammonemia, type I |
| RS1700265109 |
CPS1
|
Health Risk |
Pathogenic |
Pulmonary hypertension, neonatal |
| RS1700306908 |
SAMHD1
|
Health Risk |
Likely pathogenic |
Aicardi-Goutieres syndrome 5, Aicardi-Goutieres syndrome 5 |
| RS17003166 |
FRAS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fraser syndrome 1, Inborn genetic diseases |
| RS1700323685 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1700331549 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1700428230 |
CPS1
|
Health Risk |
Likely pathogenic |
Congenital hyperammonemia, type I |
| RS1700431210 |
LARS2
|
Health Risk |
Likely pathogenic |
— |
| RS1700436943 |
CPS1
|
Health Risk |
Likely pathogenic |
Pulmonary hypertension, neonatal |
| RS1700437565 |
CPS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital hyperammonemia, type I |
| RS1700452978 |
CPS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Pulmonary hypertension, neonatal |
| RS1700454068 |
CPS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital hyperammonemia, type I |
| RS1700455336 |
CPS1
|
Health Risk |
Likely pathogenic |
Congenital hyperammonemia, type I |
| RS1700517033 |
GLYCTK
|
Health Risk |
Conflicting classifications of pathogenicity |
D-Glyceric aciduria, D-Glyceric aciduria |
| RS1700523651 |
CPS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital hyperammonemia, type I |
| RS17005371 |
OTOF
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1700545926 |
TMIE
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 6, Autosomal recessive nonsyndromic hearing loss 6 |
| RS1700584499 |
WDPCP
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 15, Bardet-Biedl syndrome 15 |
| RS17006082 |
BBS12
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 1 |
| RS1700635072 |
CPS1
|
Health Risk |
Pathogenic |
Congenital hyperammonemia, type I |
| RS1700648887 |
SAG
|
Health Risk |
Pathogenic |
Oguchi disease-2, Oguchi disease-2 |
| RS1700663077 |
SCN2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Seizures, benign familial infantile |
| RS17006830 |
CD46
|
Health Risk |
Conflicting classifications of pathogenicity |
Atypical hemolytic-uremic syndrome with MCP/CD46 anomaly, Kidney disorder |
| RS1700715255 |
CPS1
|
Health Risk |
Likely pathogenic |
Congenital hyperammonemia, type I |
| RS1700730895 |
ATP5MC3
|
Health Risk |
Pathogenic |
Dystonia, early-onset |
| RS1700769766 |
SLC6A6
|
Health Risk |
Likely pathogenic |
Retinal degeneration, Hypotaurinemic retinal degeneration and cardiomyopathy |
| RS1700783234 |
SCN2A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS1700804080 |
CPS1
|
Health Risk |
Likely pathogenic |
— |
| RS1700874955 |
SAG
|
Health Risk |
Pathogenic |
— |
| RS1700875869 |
LZTFL1
|
Health Risk |
Likely pathogenic |
— |
| RS1700881929 |
CPS1
|
Health Risk |
Likely pathogenic |
Congenital hyperammonemia, type I |
| RS1700887978 |
CPS1
|
Health Risk |
Pathogenic |
Congenital hyperammonemia, type I |
| RS1700953301 |
SCN2A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS1700956378 |
SCN2A
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS1700979727 |
CPS1
|
Health Risk |
Pathogenic |
Congenital hyperammonemia, type I |
| RS1701063284 |
SAG
|
Health Risk |
Likely pathogenic |
— |
| RS1701105628 |
ACY1
|
Health Risk |
Likely pathogenic |
Aminoacylase 1 deficiency, Aminoacylase 1 deficiency |
| RS1701129738 |
RYR2
|
Health Risk |
Pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS1701136915 |
SCN2A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS1701138696 |
SCN2A
|
Health Risk |
Pathogenic |
Seizures, benign familial infantile |
| RS1701139863 |
SCN2A
|
Health Risk |
Likely pathogenic |
Seizures, benign familial infantile |
| RS1701171267 |
CPS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital hyperammonemia, type I |
| RS1701172643 |
CPS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital hyperammonemia, type I |
| RS1701192142 |
DNAH1
|
Health Risk |
Likely pathogenic |
Ciliary dyskinesia, primary |
| RS1701219319 |
SCN2A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS1701224136 |
SCN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Seizures, benign familial infantile |
| RS1701224556 |
SCN2A
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS1701241345 |
DNAH1
|
Health Risk |
Pathogenic |
Spermatogenic failure 18, Ciliary dyskinesia |
| RS1701282121 |
ABCA12
|
Health Risk |
Pathogenic |
— |
| RS1701306294 |
CRTAP
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 7, Osteogenesis imperfecta type 7 |
| RS1701306659 |
CRTAP
|
Health Risk |
Pathogenic/Likely pathogenic |
CRTAP-related disorder, Osteogenesis imperfecta type 7 |
| RS1701306755 |
CRTAP
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta, Osteogenesis imperfecta type 7 |
| RS1701308701 |
CRTAP
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 7, Osteogenesis imperfecta type 7 |
| RS1701318535 |
CRTAP
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 7, Osteogenesis imperfecta type 7 |
| RS1701320767 |
CRTAP
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 7, Osteogenesis imperfecta type 7 |
| RS1701330284 |
DNAH1
|
Health Risk |
Pathogenic |
Ciliary dyskinesia, primary |
| RS1701381827 |
SCN2A
|
Health Risk |
Likely pathogenic |
Seizures, benign familial infantile |
| RS1701383543 |
ABCA12
|
Health Risk |
Likely pathogenic |
— |
| RS1701516867 |
SUMF1
|
Health Risk |
Likely pathogenic |
Multiple sulfatase deficiency, Multiple sulfatase deficiency |
| RS1701517964 |
SUMF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple sulfatase deficiency, Inborn genetic diseases |
| RS1701553164 |
SCN2A
|
Health Risk |
Pathogenic |
Seizures, benign familial infantile |
| RS1701553334 |
SCN2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS1701554261 |
SCN2A
|
Health Risk |
Pathogenic |
Complex neurodevelopmental disorder, Complex neurodevelopmental disorder |
| RS1701579057 |
SCN2A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, See cases |
| RS1701579531 |
SCN2A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS1701580892 |
SCN2A
|
Health Risk |
Pathogenic |
Complex neurodevelopmental disorder, Complex neurodevelopmental disorder |
| RS1701581615 |
SCN2A
|
Health Risk |
Likely pathogenic |
Complex neurodevelopmental disorder, Complex neurodevelopmental disorder |
| RS1701581960 |
SCN2A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS1701662808 |
RFT1
|
Health Risk |
Likely pathogenic |
RFT1-congenital disorder of glycosylation, RFT1-congenital disorder of glycosylation |
| RS1701696937 |
RARB
|
Health Risk |
Likely pathogenic |
Microphthalmia, syndromic 12 |
| RS1701697098 |
RARB
|
Health Risk |
Conflicting classifications of pathogenicity |
Microphthalmia, syndromic 12 |
| RS1701741963 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1701775522 |
SUMF1
|
Health Risk |
Pathogenic |
Multiple sulfatase deficiency, Multiple sulfatase deficiency |
| RS1701834292 |
RARB
|
Health Risk |
Likely pathogenic |
Microphthalmia, syndromic 12 |
| RS1701836507 |
RARB
|
Health Risk |
Pathogenic/Likely pathogenic |
Microphthalmia, syndromic 12 |
| RS1701868598 |
PGAP1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal recessive 42 |
| RS1701869111 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1701876010 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1701905156 |
SCN2A
|
Health Risk |
Pathogenic |
Seizures, benign familial infantile |
| RS1701905708 |
SCN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Seizures, benign familial infantile |
| RS1701925645 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1701973330 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1701999328 |
SCN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 11 |
| RS1702001950 |
SCN2A
|
Health Risk |
Pathogenic |
Complex neurodevelopmental disorder, Developmental and epileptic encephalopathy |
| RS1702003246 |
SCN2A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS1702003567 |
SCN2A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS1702004667 |
SCN2A
|
Health Risk |
Likely pathogenic |
Complex neurodevelopmental disorder, Complex neurodevelopmental disorder |
| RS1702006147 |
SCN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Developmental and epileptic encephalopathy |
| RS1702006258 |
SCN2A
|
Health Risk |
Likely pathogenic |
Seizure, Seizures |
| RS1702006673 |
SCN2A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS1702008208 |
SCN2A
|
Health Risk |
Likely pathogenic |
Seizures, benign familial infantile |
| RS1702008323 |
SCN2A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, West syndrome |
| RS1702008435 |
SCN2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Episodic ataxia, type 9 |